Independent GLP-1 newsroomUpdated August 2026

The 5-minute GLP-1 briefing — prices, shortages, and provider moves.

A plain-English provider tracking what GLP-1 telehealth actually costs this week, what's in supply, and which providers earn our six-factor Brief Score. 546 providers here.

● The Desk's #1 pick · August 2026

CoreAge Rx tops the ranking — $99/mo semaglutide, $149/mo tirzepatide.

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Best for: Readers who want a price they can plan around — no teaser-rate reset, no surprise membership fee, both molecules on one account.

CoreAge Rx

94 · A

Semaglutide: $99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published
Tirzepatide: $149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published
Coverage: US only; restrictions by state, confirmed at intake
Access: Compounded

Visit CoreAge Rx Read the CoreAge Rx review →

Advertising disclosure · we may earn a commission at no extra cost to you. It never changes a Brief Score. It does decide order: providers we earn on are listed first — see our disclosure.

What's on the desk

Five ways to use this desk

546 providers tracked · 50 sourced research pieces · 214 primary-source citations.

The ranking

Every provider, ranked

Brief Score across six factors — price stability, supply, transparency, access, oversight, track record.

Open →

This week

The price tracker

Headline monthly rates and which way they moved since our last check, so you know if today's price holds.

Open →

Head-to-head

Compare providers

Any two providers, factor by factor, plus a cost calculator to see the exact disclosed line for your molecule.

Open →

The evidence

Sourced research

Trials, dosing, cost, and safety — every clinical claim tied to PubMed or an FDA label, never gestured at.

Open →

Every provider

Provider briefs

The full index — pricing, pros, cons, and a Brief Score for every telehealth provider we track.

Open →

Latest briefs

All briefs →

This week in GLP-1

The price tracker

Headline monthly compounded prices at our tracked providers, with the direction each moved since our last check. A falling line is good news for you; rising is worth a second look.

Provider	Semaglutide	Tirzepatide	Trend	Desk note
CoreAge Rx	$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published	$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published	Stableprice stable	Headline unchanged for a third straight cycle. The $99 and $149 are the 12-month prepay rates; CoreAge publishes no month-to-month price.
Eden FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.	$198/mo all-in — $99/mo for the medication plus the $99/mo Eden membership it cannot be bought without ($138 the first month, when membership is $39); compounded	$298/mo all-in — $199/mo for the medication plus the required $99/mo membership ($238 the first month); compounded	Fallingprice falling	Re-read 28 August 2026 and restated: Eden advertises compounded semaglutide at $99/mo and tirzepatide at $199/mo, but its own footnote says medication cannot be bought without an Eden membership that costs $39 the first month and $99/mo after — so the real monthly cost is $198 and $298. That is below the $239 and $349 we carried before, so the direction is down even after adding the fee back in. Brand-name Ozempic, Zepbound and Mounjaro ($1,399/mo) and Wegovy ($1,695/mo) are sold here too.
Trimi	$175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge)	$235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge)	Stableprice stable	Membership rate held flat this cycle — both molecules disclosed up front, no first-month teaser.
Sesame Care	Brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg — plus Sesame care: $59/mo only on the 12-month prepay ($708 in one charge), $69/mo on 6 months, $79/mo on 3 months, otherwise $99 billed every 28 days (13 charges a year)	Brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg) — plus Sesame care: $59/mo only on the 12-month prepay, $69/mo on 6 months, $79/mo on 3 months, otherwise $99 per 28 days	Stableprice stable	Marketplace pricing is set per provider rather than one provider rate; the brand-name Wegovy pill line held its ~$149 entry this cycle.
ShedRx	$199/mo on the 1-month plan · $179/mo on 6 months · $159/mo only on a 12-month commitment (all plans carry a 2-month minimum)	$299/mo on the 1-month plan · $269/mo on 6 months · $239/mo only on a 12-month commitment (all plans carry a 2-month minimum)	Fallingprice falling	Its lowest tirzepatide rate is $239, and that needs the 12-month commitment; the one-month rung is $299.
Sprout Health FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.	$299/mo	$349/mo	Stableprice stable	The standing compounded rates are $299 semaglutide / $349 tirzepatide; the $149/$199 on the home page are first-month-only prices under code FIRST150. A brand-name Wegovy/Zepbound path is available on the same account.
HealthRX	$190/mo month-to-month ($149 first month, renews at $165) · $133/mo on a 3-month prepay ($399) · $119/mo on 6 months ($714) · $99/mo only on the 12-month prepay ($1,188 in one charge)	$239/mo month-to-month ($193 first month, renews at $214) · $209/mo on a 3-month prepay ($627) · $199/mo on 6 months ($1,194) · $179/mo only on the 12-month prepay ($2,148 in one charge)	Stableprice stable	Company-stated tiers held flat this cycle; the LegitScript badge and a rare oral GLP tablet are the draw, but some tiers are self-reported rather than checkout-verified.
MadeMed	$239/mo injectable and $219/mo sublingual on the quarterly plan ($717 / $657 in one charge); $199 and $179 on the 6-month plan. No month-to-month option	$399/mo injectable and $299/mo sublingual on the quarterly plan ($1,197 / $897 in one charge); $369 and $279 on the 6-month plan. No month-to-month option	Stableprice stable	Publishes one price per route that holds at every dose — the cleanest dose-to-price mapping we track.
Invigor Medical	$199/mo	$339/mo	Stableprice stable	Long-running operator; mid-market pricing unchanged this cycle.
Telos Rx	From $99/mo injectable — a floor, not a rate: Telos publishes "as low as $99" and says the price depends on plan length, which is shown only inside the intake	From $139/mo injectable · from $116/mo microdosed (microdosing is tirzepatide, not semaglutide) · the needle-free option is one "Oral GLP-1" product covering either molecule, priced from $9 a day on a 3-month prepay	Stableprice stable	The $49 and $99 headlines are FIRST-MONTH rates on prepaid oral plans, not annual-lock rates: Telos itself labels them "first month", renewing at $129 and $139, and bills in 4/12/24/48-week cycles rather than calendar months. Standing injectable rates are $99 semaglutide and $139 tirzepatide; everything outside GLP-1 stays unpriced until intake.
Enhance MD	$249 every 4 weeks month-to-month (13 charges a year); $212/mo only on the 12-month prepay	$329 every 4 weeks month-to-month (13 charges a year); $280/mo only on the 12-month prepay	Stableprice stable	The ladder is fully published, but its rungs are prepay blocks: $212 and $280 are the 12-MONTH rates, while month-to-month is $249 and $329 — and every plan bills every 4 weeks, so a "monthly" plan is 13 charges a year. The $112 is $212 less a dated SUMMER50 coupon, not an entry rate.
REMEVi	$219/mo (all doses, compounded)	$319/mo (all doses, compounded)	Newnew to the tracker, no prior reading	New to the tracker on 1 August 2026, and read on the provider's own site rather than taken on trust: we checked https://remevihealth.com/pricing on 2026-08-01 and this row reflects what that page says. The line we publish is $219/mo (all doses, compounded). There is no earlier reading of ours to compare it against yet.
Ro	Not disclosed	Not disclosed	Stableprice stable	Brand-name access and insurance navigation, but compounded pricing stays off the record.
Ondra Health	$93/mo	$166/mo	Stableprice stable	$93 sema / $166 tirz — the lowest accredited nationwide line we track; brand access + LegitScript.
Vaylen	$179/mo	$239/mo	Stableprice stable	$179 sema / $239 tirz; brand + oral + LegitScript across all 50 states.
Vytora Health	$150/mo	$200/mo	Stableprice stable	$150 sema / $200 tirz nationwide; LegitScript-certified with brand-name access.
No BS RX	$179/mo month-to-month (compounded)	$249/mo month-to-month (compounded)	Newnew to the tracker, no prior reading	New to the tracker on 13 September 2026, read live off the provider's own pages that day rather than taken on trust. There is no earlier reading here to compare against, so the direction is "new" rather than stable — a first observation is not a trend. This is the one row where the thing to track is whether a promise holds: the page commits to no intro rate, and today the arithmetic agrees with it. A later reading either confirms that or is the story.
yourEra	From $79/mo — yourEra publishes only a floor; the plan tiers sit behind the intake quiz	From $159/mo — yourEra publishes only a floor; the plan tiers sit behind the intake quiz	Stableprice stable	$199 sema / $299 tirz posted openly on-site; mid-market, but the number is right there before the quiz.
Strut Health FDA warning letter, February 2026 — issued to Strut Health, LLC dba Strut. See the FDA's warning letter database.	$99/mo lozenge · $129/mo injectable (auto-refill price; 30-day supply)	$199/mo lozenge · $149/mo injectable (auto-refill price; 30-day supply)	Stableprice stable	Cheapest oral route we track at $99 — but only on auto-refill; the one-off rate runs higher.
Effecty	$160/mo	$240/mo	Stableprice stable	$160 sema / $240 tirz; LegitScript-certified with brand-name access nationwide.
NiceRx	$199/mo	$299/mo	Stableprice stable	$199 sema / $299 tirz nationwide; LegitScript-certified, established operator.
Curex FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.	$199/mo	$199/mo	Stableprice stable	Flat $199 on both molecules; LegitScript-certified and nationwide.
Amazon One Medical	Not disclosed	Not disclosed	Stableprice stable	Brand-access model through One Medical clinicians; compounded pricing isn't published, so there's no sticker to track.
AgelessRx	$139/mo	Not disclosed	Stableprice stable	Low tracked semaglutide sticker; tirzepatide price still undisclosed.
Precision Telemed	$149/mo	$199/mo	Stableprice stable	$149 sema / $199 tirz nationwide; LegitScript-certified.

Prices reflect each provider's public disclosures at last check (August 2026) and change often — confirm on the provider's own site. Not medical advice.

Shortage status

Semaglutide (brand)In supply

Off the FDA shortage list; brand supply resolved.

Tirzepatide (brand)In supply

Off the FDA shortage list since late 2024.

Compounded supplyWatch

Legal but under ongoing FDA scrutiny — sourcing matters.

Brief Score

94/100

Updated August 2026

The ranking

Best GLP-1 providers, by Brief Score

Scored on six factors: price stability · supply reliability · transparency · access breadth · clinical oversight · track record, in Brief-Score order within each group. Providers we have a commercial relationship with are listed first; the score beside each name is ours and does not change because of it.

See the dedicated best GLP-1 providers ranking, the tirzepatide-only cheapest-tirzepatide tracker, the compounded-semaglutide provider list, or read the guides and head-to-head comparisons.

Lead story · #1 here

No. 1

Brief Score

94/100

Updated August 2026

Grade A

CoreAge Rx

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Semaglutide: $99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published
Tirzepatide: $149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published
Coverage: US only; restrictions by state, confirmed at intake
Price trend: Stableprice stable

The price does not step up as your dose rises, and there is no first-month teaser that resets later
Both compounded semaglutide and tirzepatide on one account
Ships nationwide, though its own FAQ notes some states are restricted — confirm yours at intake

The advertised $99 and $149 require a 12-month plan paid in full — $1,188 and $1,788 in a single charge
No month-to-month rate is published anywhere, so the cost of trying it for one month is unknown until intake
No FDA-approved brand-name option — compounded only — and it does not publicly name its 503A/B pharmacy

Visit CoreAge Rx Read the full brief →

No. 2

Brief Score

91/100

Updated August 2026

Grade A−

Eden

A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

Semaglutide: $198/mo all-in — $99/mo for the medication plus the $99/mo Eden membership it cannot be bought without ($138 the first month, when membership is $39); compounded
Tirzepatide: $298/mo all-in — $199/mo for the medication plus the required $99/mo membership ($238 the first month); compounded
Coverage: All 50 states
Price trend: Fallingprice falling

Publishes every price before intake — both compounded molecules and all four branded pens, on one page with no quiz in front of it
A real brand-name lane: Ozempic, Zepbound, Mounjaro and Wegovy are sold alongside the compounded lines, so the FDA-approved product is available without changing providers
States "No long-term contracts" — the membership and the medication both bill monthly

The advertised $99/mo is medication only — an Eden membership at $99/mo is required to buy it at all, so the real cost is $198/mo, and the membership renews whether or not you are prescribed anything
The membership's $39 first month makes month one look like the standing rate; it is not
Brand-name pens are stocked but expensive — $1,399/mo for Ozempic, Zepbound and Mounjaro, $1,695/mo for Wegovy

FDA warning letter, June 2026 — issued to Eden Health International Inc. dba Eden. See the FDA's warning letter database.

Visit Eden Read the full brief →

No. 3

Brief Score

89/100

Updated August 2026

Grade B+

Trimi

A clean, all-in membership provider that publishes one price on both molecules nationwide and hasn't played the teaser-rate game.

Semaglutide: $175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge)
Tirzepatide: $235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge)
Coverage: All 50 states
Price trend: Stableprice stable

Both compounded semaglutide and tirzepatide disclosed up front — no quote-to-see-the-price wall
Flat membership rate held steady this cycle, with no month-one step-up
Available in all 50 states

Not the cheapest line in the ranking — several providers undercut its $175 month-to-month semaglutide
Compounded only — no FDA-approved brand-name (Wegovy/Zepbound) route
No oral or sublingual option

Visit Trimi Read the full brief →

No. 4

Brief Score

87/100

Updated August 2026

Grade B+

Sesame Care

An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

Semaglutide: Brand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg — plus Sesame care: $59/mo only on the 12-month prepay ($708 in one charge), $69/mo on 6 months, $79/mo on 3 months, otherwise $99 billed every 28 days (13 charges a year)
Tirzepatide: Brand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg) — plus Sesame care: $59/mo only on the 12-month prepay, $69/mo on 6 months, $79/mo on 3 months, otherwise $99 per 28 days
Coverage: Nationwide marketplace
Price trend: Stableprice stable

Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
You choose the provider and see the price up front — genuine marketplace transparency

A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist provider
Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
Brand-name cash prices can run high without insurance

Visit Sesame Care Read the full brief →

No. 5

Brief Score

87/100

Updated August 2026

Grade B+

ShedRx

A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.

Semaglutide: $199/mo on the 1-month plan · $179/mo on 6 months · $159/mo only on a 12-month commitment (all plans carry a 2-month minimum)
Tirzepatide: $299/mo on the 1-month plan · $269/mo on 6 months · $239/mo only on a 12-month commitment (all plans carry a 2-month minimum)
Coverage: Not disclosed
Price trend: Fallingprice falling

Offers oral/sublingual forms — wider formulary than most
Low tracked tirzepatide price
Competitive on both molecules

States-served not disclosed
Compounded only

Visit ShedRx Read the full brief →

No. 6

Brief Score

86/100

Updated August 2026

Grade B

Sprout Health

A LegitScript-certified provider that pairs low-cost compounded semaglutide and tirzepatide with a real brand-name Wegovy and Zepbound path — and a near-frictionless, often visit-free start.

Semaglutide: $299/mo
Tirzepatide: $349/mo
Coverage: Not disclosed
Price trend: Stableprice stable

LegitScript-certified with a listed address and contact line
Both compounded (from $299 semaglutide / $349 tirzepatide, with a $150-off first month) and a genuine brand-name Wegovy/Zepbound route
Low-friction intake — no labs and often no telehealth visit required

Compounded semaglutide and tirzepatide are not FDA-approved
No oral or sublingual route — injectable only
Thin transparency — no named medical director, and state availability is quiz-gated

FDA warning letter, September 2025 — issued to Sprout Health Partners LLC dba Sprout Health. See the FDA's warning letter database.

Visit Sprout Health Read the full brief →

No. 7

Brief Score

86/100

Updated August 2026

Grade B

HealthRX

A LegitScript-certified, physician-supervised provider (healthrx.com) whose real hook is breadth: injectable and a rare oral GLP tablet, on both molecules, with transparent no-insurance monthly pricing.

Semaglutide: $190/mo month-to-month ($149 first month, renews at $165) · $133/mo on a 3-month prepay ($399) · $119/mo on 6 months ($714) · $99/mo only on the 12-month prepay ($1,188 in one charge)
Tirzepatide: $239/mo month-to-month ($193 first month, renews at $214) · $209/mo on a 3-month prepay ($627) · $199/mo on 6 months ($1,194) · $179/mo only on the 12-month prepay ($2,148 in one charge)
Coverage: All 50 states
Price trend: Stableprice stable

LegitScript-certified (#50087439) — an independent trust signal most compounding providers lack
Physician-supervised telehealth with licensed-provider intake
Both molecules plus a rare oral GLP tablet — GLP injection ~$189/mo, oral ~$239/mo, GLP+GIP ~$349/mo

Core weight-loss product is compounded, which is not FDA-approved
Some tiers are company-stated on a thin public site, not checkout-verified
Brand tiers are pass-through — brand Ozempic runs ~$1,299/mo

Visit HealthRX Read the full brief →

No. 8

Brief Score

86/100

Updated August 2026

Grade B

MadeMed

Publishes a price for every dose of every route — which makes it easy to brief, and expensive if you stay low.

Semaglutide: $239/mo injectable and $219/mo sublingual on the quarterly plan ($717 / $657 in one charge); $199 and $179 on the 6-month plan. No month-to-month option
Tirzepatide: $399/mo injectable and $299/mo sublingual on the quarterly plan ($1,197 / $897 in one charge); $369 and $279 on the 6-month plan. No month-to-month option
Coverage: 40 states for the oral line; injectable semaglutide names 23
Price trend: Stableprice stable

One published price per route that does not change as the dose climbs, so a titration schedule can be costed exactly
Sublingual tablets for BOTH molecules alongside the injections — a needle-free route at a lower price than the injection
Six-month plans drop the monthly rate below the quarterly headline

Flat-at-every-dose pricing means a reader holding a low dose pays the full-dose rate
Billed quarterly rather than monthly, so the real commitment is three months of cost up front
Available in 40 states rather than nationwide

Visit MadeMed Read the full brief →

That is the top 8 of 546 providers by Brief Score — the front page, not the whole edition. The full ranking goes deeper with a one-line wire table for the whole field, and every one of the other 538 has its own dispatch on the full index of every provider we track.

See the full ranking

Assume any provider we list may compensate us — see our disclosure. It never changes a Brief Score; it does move a provider up the listing order. Prices, states and verification reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on the provider's site. Not medical advice.

The 5-minute GLP-1 briefing — prices, shortages, and provider moves.

CoreAge Rx tops the ranking — $99/mo semaglutide, $149/mo tirzepatide.

Five ways to use this desk

Latest briefs

We re-read every partner price. Eleven of seventeen had drifted

The GLP-1 pill is no longer a pipeline story

Flat-fee pricing holds while teaser tiers keep resetting

Both GLP-1 molecules stay off the FDA shortage list

Cheapest tracked tirzepatide slips again

A flat-fee pioneer drifts to the top of the price ranking

How we score a provider's price stability

The price tracker

Best GLP-1 providers, by Brief Score

CoreAge Rx

Eden

Trimi

Sesame Care

ShedRx

Sprout Health

HealthRX

MadeMed